Find a Specialist by Postal Code | Page 7 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Casey O'Connell, MD Keck Medicine of USC Los Angeles California United States
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Robert Hasserjian, MD Massachusetts General Hospital Boston Massachusetts United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Sachit Patel, MD Children's Hospital and Medical Center Specialty Pediatric Center Omaha Omaha Nebraska United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Jorge Leguizamo, MD Georgia Cancer Specialists Atlanta Georgia United States
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Thomas Prebet, MD, PhD Smilow Cancer Hospital at Yale New Haven Connecticut United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Vu Duong, MD University of Maryland Medical Center Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Amer Zeidan, MBBS Yale University and Yale Cancer Center New Haven Connecticut United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pamela Becker, MD, PhD Beckman Research Center at City of Hope Duarte California United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Maxim Norkin, MD, PhD Baptist MD Anderson Cancer Center Jacksonville Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jeffrey J. Pu, MD, PhD University of Arizona Cancer Center in Tuscon, Tuscon Arizona United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Sujit Sheth, MD New York Presbyterian Phyllis and David Komansky Children's Hospital New York City New York United States
  • Pediatric
Ilene Weitz, MD University of Southern California Los Angeles California United States
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Olatoyosi Odenike, MD University of Chicago Medicine Chicago Illinois United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Mark Litzow, MD Mayo Clinic - Rochester Rochester Minnesota United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Raajit Rampal, MD, PhD Memorial Sloan Kettering Cancer Center New York City New York United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Catherine Lai, MD, MPH University of Pennsylvania’s Perelman Center for Advanced Medicine Philadelphia Pennsylvania United States
Elizabeth Griffiths, MD Roswell Park Comprehensive Cancer Center Buffalo New York United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
David Margolis, MD Children’s Hospital of Wisconsin Milwaukee Wisconsin United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Naval Daver, MD MD Anderson Cancer Center Houston Texas United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Sharon Savage, MD National Cancer Institute – Shady Grove Rockville Maryland United States
  • Aplastic Anemia
  • Pediatric